News & Events

When it comes to getting along together, trust plays an indispensable role. While we all have an intuitive grasp of what this interpersonal investment involves, even science struggles to express exactly how it works. Denis Burdakov on the inability to measure trust with neuronal activity. 

In the fight agains bacterial pathogens, researchers are combining vaccination with targeted colonisation of the intestine by harmless microorganisms. This approach could potentially mark a turning point in the antibiotics crisis. Emma Slack and an international team have now demonstrated how highly effective oral vaccinations can be formulated against intestinal pathogens.

Researchers from the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, ETH Zurich and the University Medical Centre Freiburg have identified a novel approach to heart repair: A vitamin A metabolite could represent a targeted therapeutic approach for heart attack patients by modulating the immune response and protecting heart function in the long term. Nina Cabezas Wallscheid is leading the project. She has now developed the patent at ETH Zurich and is setting up a start-up.

More money is spent on cancer in Switzerland per capita than any other country in Europe, but this doesn’t translate to higher survival rates. Kerstin Noëlle Vokinger talks to swissinfo about possible reasons.